NICOLE ERDENEKHUYAG: Open Payments
NPI 1528538444 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 105 payments from 18 companies in 2025. Trend: 2023 $1,373 · 2024 $1,524 · 2025 $2,216
Food & beverage: $2,216
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 21 | $526 |
| ABBVIE INC. | 28 | $502 |
| Supernus Pharmaceuticals, Inc. | 11 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $150 |
| Corium, LLC | 7 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| Tris Pharma Inc | 4 | $83 |
| Collegium Pharmaceutical, Inc. | 4 | $80 |
| Almatica Pharma LLC | 3 | $78 |
| Neos Therapeutics, LP | 4 | $67 |
Products named: Auvelity, VRAYLAR, Qelbree, CAPLYTA, Azstarys, REXULTI, TRINTELLIX, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
